We are live on
!
Find out more
CSS
Cubist Systematic Strategies Portfolio holdings
AUM
$21B
1-Year Est. Return
21.48%
This Fund
S&P 500
This Quarter
Est. Return
-4.64%
1 Year Est. Return
+21.48%
3 Year Est. Return
+78.34%
5 Year Est. Return
+110.56%
10 Year Est. Return
+239.04%
AUM
$11.8B
AUM Growth
+$1.34B
(+13%)
Cap. Flow
+$2.18B
Cap. Flow
% of AUM
18.39%
Top 10 Holdings %
Top 10 Hldgs %
3.51%
Holding
4,052
New
613
Increased
1,643
Reduced
1,246
Closed
518
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Abbott
ABT
|
+$34.6M |
| 2 |
Workday
WDAY
|
+$33.5M |
| 3 |
FRC
First Republic Bank
FRC
|
+$31.8M |
| 4 |
Zoetis
ZTS
|
+$31.3M |
| 5 |
Synchrony
SYF
|
+$31M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Medtronic
MDT
|
+$35.7M |
| 2 |
Honeywell
HON
|
+$31.7M |
| 3 |
International Paper
IP
|
+$30.5M |
| 4 |
Archer Daniels Midland
ADM
|
+$23.8M |
| 5 |
Emerson Electric
EMR
|
+$22.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.12% |
| 2 | Financials | 17.75% |
| 3 | Healthcare | 12.17% |
| 4 | Consumer Discretionary | 11.8% |
| 5 | Industrials | 11.52% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2151
Seer Inc
SEER
$119M
| $864K | 0.01% |
56,673
-22,559
| -28% | -$349K |
|
2152
Las Vegas Sands
LVS
$29.6B
| $860K | 0.01% |
22,118
-54,822
| -71% | -$2.27M |
|
2153
Univest Financial
UVSP
$1.18B
| $860K | 0.01% |
32,156
+21,956
| +215% | +$645K |
|
2154
Cannae Holdings
CNNE
$652M
| $858K | 0.01% |
35,874
+7,420
| +26% | +$209K |
|
2155
Haemonetics
HAE
$3.97B
| $858K | 0.01% |
13,571
-48,935
| -78% | -$2.66M |
|
2156
ALX Oncology
ALXO
$267M
| $857K | 0.01% |
50,694
-9,801
| -16% | -$167K |
|
2157
Amerant Bancorp
AMTB
$1.14B
| $857K | 0.01% |
27,142
+19,007
| +234% | +$629K |
|
|
NOTV
2158
DELISTED
Inotiv
NOTV
| $857K | 0.01% |
32,737
+21,932
| +203% | +$616K |
|
|
NSTG
2159
DELISTED
NanoString Technologies, Inc.
NSTG
| $855K | 0.01% |
24,617
+8,891
| +57% | +$306K |
|
|
CCMP
2160
DELISTED
CMC Materials, Inc. Common Stock
CCMP
| $855K | 0.01% |
4,613
-14,049
| -75% | -$2.59M |
|
2161
Criteo S.A. Ordinary Shares
CRTO
$867M
| $852K | 0.01% |
31,269
-489
| -2% | -$15.6K |
|
2162
Chord Energy
CHRD
$7.62B
| $851K | 0.01% |
5,814
+3,597
| +162% | +$498K |
|
2163
LanzaTech
LNZA
$69M
| $850K | 0.01% |
871
-1,504
| -63% | -$1.46M |
|
|
BBT
2164
Beacon Financial Corp
BBT
$2.66B
| $848K | 0.01% |
29,274
+21,714
| +287% | +$653K |
|
2165
Texas Instruments
TXN
$257B
| $848K | 0.01% |
4,621
-56,376
| -92% | -$9.94M |
|
2166
IDEAYA Biosciences
IDYA
$3.55B
| $847K | 0.01% |
75,704
+74,499
| +6,182% | +$1.1M |
|
|
ITOS
2167
DELISTED
iTeos Therapeutics
ITOS
| $847K | 0.01% |
26,335
-27,172
| -51% | -$987K |
|
2168
SITE Centers
SITC
$155M
| $847K | 0.01% |
64,936
-208,712
| -76% | -$2.54M |
|
2169
Viking Therapeutics
VKTX
$3.94B
| $847K | 0.01% |
282,306
+239,182
| +555% | +$858K |
|
2170
Eastern Bankshares
EBC
$5.29B
| $846K | 0.01% |
39,292
+16,738
| +74% | +$356K |
|
2171
Sanmina
SANM
$10.9B
| $843K | 0.01% |
20,848
-47,534
| -70% | -$1.89M |
|
2172
Intellia Therapeutics
NTLA
$1.68B
| $842K | 0.01% |
+11,589
| New | +$982K |
|
|
HYZN
2173
DELISTED
Hyzon Motors Inc. Class A Common Stock
HYZN
| $841K | 0.01% |
2,631
+824
| +46% | +$228K |
|
2174
GeoPark
GPRK
$604M
| $838K | 0.01% |
56,084
+41,370
| +281% | +$582K |
|
2175
Holley
HLLY
$378M
| $838K | 0.01% |
60,262
+48,262
| +402% | +$619K |
|
Similar funds
GIM
ECM
JFL
BAM
SF
WIM
AIM
SIG
Cubist Systematic Strategies's Q1 2022 Portfolio in Review
As of Q1 2022, Cubist Systematic Strategies held 4,052 positions worth $11.8B, up 13% from $10.5B the previous quarter. Its ten largest holdings account for 3.5% of the portfolio.
Cubist Systematic Strategies deployed $2.18B of net new capital in Q1 2022, opening 613 new positions and adding to 1,643 existing holdings. Its largest new stake was Trine II Acquisition Corp.: 2,018,590 shares worth $20.1M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 19% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Medtronic, an estimated $35.7M trimmed.
- Cubist Systematic Strategies's largest Q1 2022 buy was Trine II Acquisition Corp.: 2,018,590 shares worth $20.1M.
- Cubist Systematic Strategies added most to Abbott in Q1 2022, an estimated $34.6M increase.
- Cubist Systematic Strategies's biggest Q1 2022 reduction was Medtronic, cutting an estimated $35.7M.
- Cubist Systematic Strategies fully exited Trine II Acquisition Corp. Units, each consisting of one Class A Ordinary Share and one-half of one redeemable warrant in Q1 2022, selling an estimated $20.6M.
- Cubist Systematic Strategies's ten largest holdings make up 3.5% of its $11.8B portfolio in Q1 2022.
- Cubist Systematic Strategies opened 613 new positions and closed 518 in Q1 2022.
- Cubist Systematic Strategies's portfolio value rose 13% quarter-over-quarter to $11.8B.
Based on Cubist Systematic Strategies's 13F filing for Q1 2022, filed 16 May 2022.